title: Fetal therapy in fetal thyrotoxicosis: a case report.
abstract: BACKGROUND
  Fetal thyrotoxicosis, often caused by maternal Grave's disease, can have adverse effects on fetal outcomes, such as growth impairment or fetal hydrops. Therefore, intrauterine treatment is recommended.
  
  
  OBJECTIVE
  To describe the experience of intrauterine medical treatment of fetal thyrotoxicosis.
  
  
  METHODS
  A 19-year-old woman with a history of Grave's disease in a euthyroid clinical status after subtotal thyroidectomy became pregnant 2 months after thyroidectomy. At gestational age 28 weeks, persistent fetal tachycardia was identified and the diagnosis of fetal thyrotoxicosis was established by fetal thyroid function test on umbilical cord blood obtained by cordocentesis. Intrauterine treatment for hyperthyroidism was initiated with antithyroid drugs (150 mg/day of propylthiouracil) via maternal oral administration. Fetal heart rate, size of fetal thyroid gland and umbilical cord blood sampling for thyroid function test were monitored. Fetal heart rate became normal and fetal thyroid function tested on fetal cord blood at 1 month after antithyroid fetal therapy was also normal. Fetal thyrotoxicosis improved but the mother had some degree of hypothyroidism from fetal therapy and needed thyroid hormone replacement. The remaining course of gestation was uneventful. The patient had spontaneous labor and delivery at 38 weeks of gestation resulting in normal female baby, 2,900 g, and had no clinical of neonatal thyrotoxicosis. Maternal thyroid medications were stopped immediately after birth.
  
  
  CONCLUSIONS
  Intrauterine treatment of fetal thyrotoxicosis with medication via the maternal circulation can possibly improve fetal outcome.
authors.affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. psrisupundit@yahoo.com
authors.forename: Kasemsri
authors.initials: K
authors.lastname: Srisupundit
authors.forename: Supatra
authors.initials: S
authors.lastname: Sirichotiyakul
authors.forename: Fuanglada
authors.initials: F
authors.lastname: Tongprasert
authors.forename: Suchaya
authors.initials: S
authors.lastname: Luewan
authors.forename: Theera
authors.initials: T
authors.lastname: Tongsong
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000008:administration & dosage; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D046128:Fetal Therapies / Q000379:methods*; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D013971:Thyrotoxicosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D013956:Antithyroid Agents